Profile of Immunological Biomarkers in Behcet’s Syndrome: a Large-Scale Single-Center Real-World Study

Jiachen Li,Feng Sun,Yingni Li,Jing Zhao,Rulin Jia,Hongyan Wang,Xiaohong Xiang,Xiaolin Sun,Chengbin Chen,Haixin Xu,Zhanguo Li,Tian Liu
DOI: https://doi.org/10.1007/s10238-024-01462-5
IF: 4.6
2024-01-01
Clinical and Experimental Medicine
Abstract:Behcet's syndrome (BS) is a vasculitis characterized by immune dysregulation. Biomarkers are valuable for assessing clinically atypical pathogenesis. We aimed to investigate the distribution of different biomarkers and their effects on the clinical features of patients with BS in a large-scale, real-world study. This is a retrospective, single-center study. In total, 502 patients diagnosed with BS were enrolled in this study. We analyzed the clinical features of this cohort and divided patients’ symptoms into six categories, including mucocutaneous, articular, neurological, gastrointestinal, vascular, and ocular involvements. HLA-B51 cells, autoantibodies, and subsets of immune cells from the patients were tested. Pearson’s correlation, Wilcoxon rank sum test and multivariate logistic regression were used for data analysis. Various autoantibodies were detected in the serum of 40.8
What problem does this paper attempt to address?